EP3129006
IMMUNOSUPPRESSANT FORMULATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
8.4.2015:
27.1.2021:
15735733.6
:
7.4.2035
:
IMMUNOSUPPRESSANT FORMULATION
8.4.2015
27.1.2021
:
Novartis AG:
Lichtstrasse 35, 4056 Basel, CH
:
BOUILLOT, Philippe Michel Rene:
4002 Basel, CH
:
REYNAUD, Emeric:
4002 Basel, CH
:
201461977806 P:
10.4.2014:
US
:
IB2015052552:
8.4.2015
:
A61K 9/16, A61K 9/20, A61K 9/28, A61K 31/397